SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-066115
Filing Date
2018-11-06
Accepted
2018-11-06 06:03:30
Documents
45
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-18998_110q.htm 10-Q 546936
2 EX-31.1 a18-18998_1ex31d1.htm EX-31.1 13439
3 EX-31.2 a18-18998_1ex31d2.htm EX-31.2 13427
4 EX-32.1 a18-18998_1ex32d1.htm EX-32.1 7907
  Complete submission text file 0001104659-18-066115.txt   3234464

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mdgl-20180930.xml EX-101.INS 781762
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mdgl-20180930.xsd EX-101.SCH 25732
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mdgl-20180930_cal.xml EX-101.CAL 27733
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mdgl-20180930_def.xml EX-101.DEF 85514
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mdgl-20180930_lab.xml EX-101.LAB 251644
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mdgl-20180930_pre.xml EX-101.PRE 183188
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 181161384
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences